Corvus Pharmaceuticals (CRVS) Current Leases (2019 - 2026)
Corvus Pharmaceuticals (CRVS) recorded quarterly Current Leases of $428000.0 in Q1 2026, up 6.2% quarter-over-quarter from $403000.0 in Q4 2025, and up 34.17% on a YoY basis from $319000.0 in Q1 2025.
Corvus Pharmaceuticals (CRVS) Current Leases (2019 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $428000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 34.17% year-over-year to $428000.0; the TTM figure through Mar 2026 stood at $428000.0 (up 34.17% YoY), while the FY2025 annual figure was $403000.0, up 117.84% from the prior year.
- Current Leases was $428000.0 for Q1 2026 at Corvus Pharmaceuticals, up from $403000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.4 million in Q4 2023 to a low of $185000.0 in Q4 2024.
- Historically, Current Leases has averaged $827588.2 across 5 years, with a median of $1.0 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Current Leases tumbled 86.54% in 2024, then surged 117.84% in 2025.
- A 5-year view of Current Leases shows it stood at $1.2 million in 2022, then grew by 11.89% to $1.4 million in 2023, then sank by 86.54% to $185000.0 in 2024, then soared by 117.84% to $403000.0 in 2025, then rose by 6.2% to $428000.0 in 2026.
- The last three Current Leases figures came in at $428000.0 (Q1 2026), $403000.0 (Q4 2025), and $379000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Corvus Pharmaceuticals | 1.00 Bn | 766.75 Mn | - | 428,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 428,000.00 |
| Dec 31, 2025 | 403,000.00 |
| Sep 30, 2025 | 379,000.00 |
| Jun 30, 2025 | 355,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Dec 31, 2024 | 185,000.00 |
| Sep 30, 2024 | 354,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 1.26 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.09 Mn |
| Dec 31, 2021 | 1.05 Mn |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 1.15 Mn |